Literature DB >> 18339866

Proteinase-activated receptor-1-triggered activation of tumor progression locus-2 promotes actin cytoskeleton reorganization and cell migration.

Maria Hatziapostolou1, Christos Polytarchou, Dimitrios Panutsopulos, Lidija Covic, Philip N Tsichlis.   

Abstract

Tumor progression locus 2 (Tpl2), a mitogen-activated protein kinase kinase kinase (MAP3K) that is activated by provirus insertion in retrovirus-induced rodent lymphomas and mammary adenocarcinomas, is known to transduce Toll-like receptor, interleukin 1, tumor necrosis factor alpha, and CD40 signals and to play an important role in inflammation. Here we show that Tpl2 is also required for the transduction of cell migration and gene expression signals originating in the G-protein-coupled receptor proteinase-activated receptor 1 (PAR1). PAR1 signals transduced by Tpl2 activate Rac1 and focal adhesion kinase, and they are required for reorganization of the actin cytoskeleton and cell migration. PAR1 expressed in fibroblasts can be triggered by proteinases produced by tumor cells, and PAR1 expressed in tumor cells can be triggered by proteinases produced by fibroblasts. These data suggest that signals that regulate cell migration and gene expression flow between stromal and tumor cells in both directions and that Tpl2 plays a pivotal role in this process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339866     DOI: 10.1158/0008-5472.CAN-07-5793

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Tpl2 inhibitors thwart endothelial cell function in angiogenesis and peritoneal dissemination.

Authors:  Wen-Jane Lee; Keng-Hsin Lan; Chiang-Ting Chou; Yu-Chiao Yi; Wei-Chih Chen; Hung-Chuan Pan; Yen-Chun Peng; Keh-Bin Wang; Yi-Ching Chen; Te-Hsin Chao; Hsing-Ru Tien; Wayne Huey Herng Sheu; Meei-Ling Sheu
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

2.  MicroRNA 375 mediates the signaling pathway of corticotropin-releasing factor (CRF) regulating pro-opiomelanocortin (POMC) expression by targeting mitogen-activated protein kinase 8.

Authors:  Nan Zhang; Jun-kai Lin; Juan Chen; Xiong-fei Liu; Jia-li Liu; Hao-shu Luo; Yue-qin Li; Sheng Cui
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

3.  Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.

Authors:  Jaroslaw Cisowski; Katie O'Callaghan; Athan Kuliopulos; John Yang; Nga Nguyen; Qing Deng; Eric Yang; Michael Fogel; Sarah Tressel; Caitlin Foley; Anika Agarwal; Stephen W Hunt; Tom McMurry; Larry Brinckerhoff; Lidija Covic
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

4.  Tumor progression locus 2 mediates signal-induced increases in cytoplasmic calcium and cell migration.

Authors:  Maria Hatziapostolou; Georgios Koukos; Christos Polytarchou; Filippos Kottakis; Oksana Serebrennikova; Athan Kuliopulos; Philip N Tsichlis
Journal:  Sci Signal       Date:  2011-08-23       Impact factor: 8.192

5.  Tpl2 ablation promotes intestinal inflammation and tumorigenesis in Apcmin mice by inhibiting IL-10 secretion and regulatory T-cell generation.

Authors:  Oksana B Serebrennikova; Christos Tsatsanis; Changchuin Mao; Elias Gounaris; Wenying Ren; Linda D Siracusa; Aristides G Eliopoulos; Khashayarsha Khazaie; Philip N Tsichlis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

6.  The Tpl2 Kinase Regulates the COX-2/Prostaglandin E2 Axis in Adipocytes in Inflammatory Conditions.

Authors:  Flavien Berthou; Franck Ceppo; Karine Dumas; Fabienne Massa; Bastien Vergoni; Susana Alemany; Mireille Cormont; Jean-François Tanti
Journal:  Mol Endocrinol       Date:  2015-05-28

7.  Ablation of tumor progression locus 2 promotes a type 2 Th cell response in Ovalbumin-immunized mice.

Authors:  Wendy T Watford; Chun-Chi Wang; Christos Tsatsanis; Lisa A Mielke; Aristides G Eliopoulos; Constantine Daskalakis; Nicolas Charles; Sandra Odom; Juan Rivera; John O'Shea; Philip N Tsichlis
Journal:  J Immunol       Date:  2009-12-02       Impact factor: 5.422

8.  TPL2 kinase is a suppressor of lung carcinogenesis.

Authors:  Katerina Gkirtzimanaki; Kalliopi K Gkouskou; Urszula Oleksiewicz; Georgios Nikolaidis; Dimitra Vyrla; Michalis Liontos; Vassiliki Pelekanou; Dimitris C Kanellis; Kostantinos Evangelou; Efstathios N Stathopoulos; John K Field; Philip N Tsichlis; Vassilis Gorgoulis; Triantafillos Liloglou; Aristides G Eliopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

9.  Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice.

Authors:  Irene Kyrmizi; Marianna Ioannou; Maria Hatziapostolou; Philip N Tsichlis; Dimitrios T Boumpas; Ioannis Tassiulas
Journal:  J Leukoc Biol       Date:  2013-07-29       Impact factor: 4.962

10.  Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis.

Authors:  Jennifer Jager; Thierry Grémeaux; Teresa Gonzalez; Stéphanie Bonnafous; Cyrille Debard; Martine Laville; Hubert Vidal; Albert Tran; Philippe Gual; Yannick Le Marchand-Brustel; Mireille Cormont; Jean-François Tanti
Journal:  Diabetes       Date:  2009-10-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.